A new study has tested the hypothesis that patients with serum antibodies against recombinant myelin oligodendrocyte glycoprotein (MOG) and purified myelin basic protein (MBP) are at an increased ...

Diosynth is a global leader in technology-driven process development and cGMP manufacturing of recombinant proteins, monoclonal antibodies and peptides. The incubators will be used in MBP bioprocess ...